↓ Skip to main content

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial

Overview of attention for article published in BMC Cancer, May 2012
Altmetric Badge

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial
Published in
BMC Cancer, May 2012
DOI 10.1186/1471-2407-12-163
Pubmed ID
Authors

Alexandra D Jensen, Anna V Nikoghosyan, Karen Lossner, Klaus K Herfarth, Jürgen Debus, Marc W Münter

Abstract

The COSMIC trial is designed to evaluate toxicity in dose-escalated treatment with intensity-modulated radiotherapy (IMRT) and carbon ion boost for malignant salivary gland tumors (MSGT) of the head and neck including patients with inoperable/ incompletely resected MSGTs (R2-group) and completely resected tumors plus involved margins or perineural spread (R1-group).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 2%
Germany 1 2%
Unknown 44 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 13%
Researcher 6 13%
Student > Master 6 13%
Student > Postgraduate 5 11%
Other 4 9%
Other 9 20%
Unknown 10 22%
Readers by discipline Count As %
Medicine and Dentistry 17 37%
Nursing and Health Professions 4 9%
Physics and Astronomy 3 7%
Agricultural and Biological Sciences 3 7%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 7 15%
Unknown 11 24%